- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on High-risk Patient in Australia
Total 177 results
-
Medical University of ViennaRecruitingClinical High Risk for Psychosis | Ultra-high Risk for Psychosis | At-risk Mental StateAustria
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
Medical University of ViennaCompletedPerioperative | Brain Natriuretic Peptide | Supplemental Oxygen | Cardiac Risk PatientsAustria
-
University Hospital, Basel, SwitzerlandCompletedPostoperative Complications | Intraoperative Complications | Patient Safety | Risk ManagementNew Zealand, Switzerland, United States, Netherlands, Spain, Austria, Turkey, United Kingdom, Australia, Greece, Ireland, Italy
-
Ikaria Bioscience Pty LtdRecruitingTo Reduce the LDL-C Level in Hypercholesteremia Adult Patients | Combination for Subgroup High LDL-c Patients With Other ComorbiditiesAustralia
-
OrygenNational Institute of Mental Health (NIMH); University of California, Davis; University...UnknownPersonality Disorders | Psychotic Disorders | Clinical High RiskAustralia
-
Edith Cowan UniversityFlinders University; The University of Western AustraliaCompleted
-
Edith Cowan UniversityFlinders University; The University of Western AustraliaCompleted
-
Edith Cowan UniversityFlinders University; The University of Western AustraliaCompleted
-
Royal North Shore HospitalRecruiting
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH); Yale University; OrygenRecruitingPsychosis | Remission | Conversion | Clinical High RiskUnited States, United Kingdom, Canada, Italy, Australia, Chile, China, Denmark, Germany, Hong Kong, Korea, Republic of, Singapore, Spain, Switzerland
-
Rene KahnCompletedUltra High Risk for PsychosisSpain, Austria, Germany, Israel, Italy, Netherlands, Norway, Switzerland, United Kingdom
-
Bayside HealthCompletedMechanically Ventilated Patients | Intensive Care | Sedated PatientsAustralia
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
Kepler University HospitalRISC Software GmbH; innovethic eU; FiveSquare GmbHNot yet recruiting
-
Medical University of ViennaActive, not recruitingCardiovascular Risk FactorAustria
-
Medical University of ViennaCompletedPatient SatisfactionAustria
-
Gustave Roussy, Cancer Campus, Grand ParisNational Cancer Institute, FranceTerminatedVery High Risk NeuroblastomaItaly, Austria, France, Netherlands, Spain
-
National Cancer Institute (NCI)Active, not recruitingGanglioneuroblastoma | High Risk NeuroblastomaUnited States, New Zealand, Australia
-
Foundation for Cardiovascular Research, ZurichAbbott Medical DevicesUnknownHeart Septal Defects, Atrial | Embolism, ParadoxicalAustralia, Austria, Belgium, Switzerland
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
Novartis PharmaceuticalsCompletedAML and High Risk MDSGermany, Italy, France, Netherlands, United States, Australia, Japan
-
German Cancer Research CenterUniversity Hospital Freiburg; ABX CRO; Friedrich-Alexander-Universität Erlangen-NürnbergCompletedProstate Cancer | Prostate Cancer Metastatic | High-risk Prostate Cancer | Lymphnode MetastasisAustria, Germany
-
Royal North Shore HospitalCompletedCancer | Palliative Care | Patient Reported Outcome Measures | Caregiver | Digital Health | Wearable Electronic DevicesAustralia
-
University of AdelaideCompletedIndividuals at Risk of Developing DiabetesAustralia
-
Monash UniversityRecruitingCardiovascular Risk Factors | Cognitive Function 1, Social | Poor Glycemic ControlAustralia
-
Bio-Thera SolutionsGeorge Clinical Pty LtdActive, not recruiting
-
ECRI bvUniversity of Bern; European Cardiovascular Research Center; Terumo Medical Corporation and other collaboratorsCompletedCoronary Artery Disease | PCI | High Bleeding RiskNetherlands, France, United Kingdom, Australia, Singapore, Japan, Italy, Poland, Spain, Switzerland, Israel, Argentina, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, India, Korea, Republic... and more
-
University of MelbourneCompletedKnee Osteoarthritis | Patient EmpowermentAustralia
-
Flinders Universitymedac GmbH; University of South AustraliaRecruitingRheumatoid Arthritis | Endothelial Dysfunction | Cardiovascular Risk Factor | Stiffness, AorticAustralia
-
Australian and New Zealand Intensive Care Research...CompletedPatients on Extracorporeal Membrane OxygenationAustralia, New Zealand
-
Kite, A Gilead CompanyRecruitingHigh-risk Large B-cell Lymphoma (LBCL)United States, Austria, Spain, Italy, Australia, Germany, Netherlands, Canada, Portugal, United Kingdom, France
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknownCritically Injured Mechanically Ventilated Trauma PatientsAustralia
-
Amsterdam UMCRecruitingBarrett Esophagus | Submucosal Esophageal Adenocarcinoma | High-risk Mucosal Esophageal AdenocarcinomaNetherlands, Belgium, Australia, United Kingdom, Germany, Switzerland
-
Medical University of GrazRecruitingFrailty | Cardiovascular Risk FactorAustria
-
La Trobe UniversityAustin HealthCompleted
-
Medical University of GrazRecruiting
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownBarrett Esophagus | Adenocarcinoma Esophagus | Submucosal Esophageal Adenocarcinoma | High-risk Mucosal Esophageal AdenocarcinomaFrance, United Kingdom, Belgium, Germany, Switzerland, Australia, Netherlands
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
St John of God Hospital, ViennaWithdrawn
-
Gustave Roussy, Cancer Campus, Grand ParisRecruitingHigh-Risk NeuroblastomaFrance, Spain, United Kingdom, Norway, Sweden, Finland, Australia, Czechia, Italy, Netherlands, Slovenia, Switzerland, Belgium, Denmark, Greece, Lithuania
-
Bayside HealthCompletedLength of ICU Stay | Pressure Ulcer, Area | Pressure Ulcer, Grade | Albumin Level | Risk ScoreAustralia
-
Murdoch Childrens Research InstituteRecruitingPatient-Controlled AnalgesiaAustralia
-
Medical University of GrazCompletedNFAT Regulated Gene Expression in Tacrolimus Treated PatientsAustria
-
Bayside HealthAustralian and New Zealand College of AnaesthetistsCompletedPatients Undergoing Cardiothoracic SurgeryAustralia
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Refractory Neuroblastoma | High Risk NeuroblastomaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
EBG MedAustron GmbHRecruiting
-
EBG MedAustron GmbHRecruitingLow Risk Prostate Cancer | Intermediate Risk Prostate CancerAustria